Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Olema Pharmaceuticals Inc increased its cash reserves by 189.17%, or 44.84m. Cash Flow from Financing totalled 133.42m or -- of revenues. In addition the company used 83.73m for operations while cash used for investing totalled 4.85m.
Cash flow per share | -2.06 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 3.97 |
---|---|
Tangible book value per share | 3.97 |
More ▼
Balance sheet in USDView more
Current ratio | 9.13 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼